Altria Group is a leading company in the tobacco and consumer goods industry, primarily known for its extensive portfolio of cigarette brands, including Marlboro
The company engages in the manufacture, marketing, and sale of various tobacco products and related offerings. Beyond traditional tobacco, Altria has been expanding its focus on smoke-free alternatives, such as e-vapor products and heated tobacco devices, as part of its strategy to adapt to changing consumer preferences and regulatory landscapes. Additionally, Altria is involved in wine production and has made investments in cannabis and other non-tobacco businesses, reflecting a commitment to diversifying its product range and engaging with emerging markets.
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
As volatility returns to the S&P 500 index, some investors may consider safer alternatives for their portfolios. Wall Street analysts agree with upside
Altria generated $8.6 billion in free cash flow in 2024, down from over $9 billion in 2023. This year, free cash flow is forecast to decline again to $8.2 billion.
As volatile times have taken over the stock market in recent weeks, institutional capital has started to look to the safer areas of the market, leaving hints.
Tobacco company Altria (NYSEMO) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 1.6% year on year to $5.11 billion. Its non-GAAP profit of $1.29 per share was 0.8% above analysts’ consensus estimates.
